13 results found.

Keratoconjunctivitis Sicca, or Dry Eye Syndrome Clinical Trial using dexamethasone, artificial tears

Baylor College of Medicine - Recruiting 18 years or older.
- Effects of Conventional Dry Eye Treatments on the Ocular Surface Response to Low Humidity Environment in Patients With Keratoconjunctivitis Sicca..
dexamethasone, artificial tears

Turner Syndrome, Ovarian Failure, Premature, Sex Chromosome Aberr Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome.

Dry Eye Clinical Trial using FML 0.1% eyedrops; Liquifilm artificial tears eyedrops

Instituto Universitario de Oftalmobiolog¡a Aplicada - Recruiting 18 years or older.
- Randomized, Double-Masked, Vehicle-controlled Phase III Trial on the Safety/Efficacy of FMLr 0.1% in the Treatment of the Inflammatory Exacerbation Provoked by Exposure to an Adverse Controlled Environment in Patients With Dry Eye Disease.
FML 0.1% eyedrops; Liquifilm artificial tears eyedrops

Dry Eye Clinical Trial using carboxymethylcellulose; xanthan gum

SIFI SpA - Recruiting 60 years or older.
- Evaluation of Xanthan Gum Eye Drops in Patients With Dry Eye.
carboxymethylcellulose; xanthan gum

Dry Eye Disease Clinical Trial using In vivo confocal microscopy (IVCM)

Massachusetts Eye and Ear Infirmary - Recruiting 18 years or older.
- Ocular Surface Immune Response in Dry Eye Disease: Analysis of Conjunctival and Peripheral Corneal Immune Cell Alterations by In Vivo Confocal Microscopy and Clinical Correlation.
In vivo confocal microscopy (IVCM)

Dry Eye Syndromes Clinical Trial using MIM-D3 Ophthalmic Solution; Vehicle

Mimetogen Pharmaceuticals USA, Inc. - Recruiting 18 years or older.
- A Phase 3, Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of 1% MIM-D3 Ophthalmic Solution in the Environment, and During Challenge in the Controlled Adverse Environmental (CAE) Model for the Treatment of Dry Eye.
MIM-D3 Ophthalmic Solution; Vehicle

Dry Eye Disease Clinical Trial using Loteprednol etabonate; Artificial Tears; Restasis

Holprovision - Recruiting 21 years to 80 years.
- .
Loteprednol etabonate; Artificial Tears; Restasis

Dry Eye Clinical Trial using Artificial Tears

Allergan - Recruiting 40 years or older.
- .
Artificial Tears

Dry Eye, or Fibromyalgia Clinical Trial

University of Michigan - Recruiting 18 years or older.
- .

Dry Eye Clinical Trial using Electrode device

Oculeve, Inc. - Recruiting 18 years or older.
- A Non-Randomized, Open-Label Study to Determine the Effect of Electrical Stimulation on Tear Production.
Electrode device

Pterygium, Dry Eye, or Tumor Clinical Trial

National Taiwan University Hospital - Recruiting 12 years to 85 years.
- Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders.

Dry Eye Clinical Trial using 0.05% cyclosporin eye drop

Chulalongkorn University - Recruiting 18 years to 80 years.
- Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESHr in Patients With Moderate to Severe Dry Eyes.
0.05% cyclosporin eye drop

Dry Eye Syndrome Clinical Trial using Essential fatty acid supplement

University of Texas Southwestern Medical Center - Recruiting 18 years to 90 years.
- A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome.
Essential fatty acid supplement